[February 08, 2013]

Research and Markets: European Markets for Diabetes Monitoring, Treatment and Drug Delivery - Expected to Exceed 7.7 billion by 2019.

Research and Markets (http://www.researchandmarkets.com/research/73cjdb/european_markets) has announced the addition of the "European Markets for Diabetes Monitoring, Treatment and Drug Delivery" report to their offering.

The European market for diabetes diagnosis, treatment and drug delivery is expected to exceed 7.7 billion by 2019.

This market includes traditional blood glucose meters, continuous glucose monitoring systems, blood glucose test strips, lancets and lancing devices, insulin, insulin syringes, insulin pens and insulin pumps. Market growth is expected to be fuelled by an increasing number of diabetics and improved education regarding he importance of blood glucose management. Factors such as high obesity rates, poor diet and lack of exercise will contribute to the growing type 2 diabetic population.

Scope: This report pertains to a forecast period of 10 years (2009- 2019) for Austria, Belgium, Denmark, Finland, France, Germany, Italy, Luxembourg, Netherlands, Norway, Portugal, Spain, Sweden, Switzerland, U.K.

Key Topics Covered:

Executive Summary

Research Methodology

European Diabetes Diagnosis, Treatment And Drug Delivery Market

Country Profiles

Traditional Blood Glucose Monitoring Market

Blood Glucose Meter Market

Blood Glucose Test Strip Market

Lancet And Lancing Device Market

Continuous Glucose Monitoring Market

Insulin Market

Insulin Pen Market

Insulin Syringe Market

Insulin Pump Market

Appendix 1: Artificial Pancreas

Abbreviations

Companies Mentioned

- Sanofi

- Johnson & Johnson

- Eli Lilly

- Abbott

- Roche

- Bayer

- Medtronic

- Menarini

- Artsana

- Becton Dickinson

- Terumo

- Sooil

- B Braun

- Dexcom

- Novo Nordisk

For more information visit http://www.researchandmarkets.com/research/73cjdb/european_markets

[ Back To Technology News's Homepage ]